002773.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 08:23):

Chengdu Kanghong Pharmaceuticals Group Co., Ltd engages in the research, development, production, and sale of biological products, Chinese medicines, and chemical drugs in China...

Stats
Dzisiejszy wolumen	18.11M
Średni wolumen	6.62M
Kapitalizacja rynkowa	18.93B
EPS	CNY0.331 ( 2023-10-26 )
Następna data zysków	( CNY0 ) 2024-05-16
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	16.57
ATR14	CNY0.0320 (0.15%)

Wolumen Korelacja

Długi: -0.18 (neutral)

Krótki: 0.37 (neutral)

Signal:(45.466) Neutral

Chengdu Kanghong Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Chengdu Kanghong Korelacja - Waluta/Towar

0.25
( neutral )

0.18
( neutral )

0.00
( neutral )

0.07
( neutral )

0.00
( neutral )

-0.04
( neutral )

Chengdu Kanghong Finanse

Annual	2023
Przychody:	CNY3.96B
Zysk brutto:	CNY3.52B (88.92 %)
EPS:	CNY1.140

FY	2023
Przychody:	CNY3.96B
Zysk brutto:	CNY3.52B (88.92 %)
EPS:	CNY1.140

FY	2022
Przychody:	CNY3.39B
Zysk brutto:	CNY3.00B (88.55 %)
EPS:	CNY0.980

FY	2021
Przychody:	CNY3.61B
Zysk brutto:	CNY3.25B (90.16 %)
EPS:	CNY0.460

Financial Reports:

No articles found.

Chengdu Kanghong

Chengdu Kanghong Pharmaceuticals Group Co., Ltd engages in the research, development, production, and sale of biological products, Chinese medicines, and chemical drugs in China. It offers ophthalmic systems, central nervous systems, digestive systems, and other system drugs. The company was founded in 1996 and is headquartered in Chengdu, China.